Skip to main content

Washington, D.C. — Today, the U.S. Food and Drug Administration expanded the approval of the COVID-19 treatment Veklury (remdesivir) to include pediatric patients 28 days of age and older weighing at least seven pounds with positive results of direct SARS-CoV-2 viral testing, who are:


A curious correlation caught the attention of twitter and academic researchers this month: As COVID-19 cases increased in the U.S., the number of bad reviews claiming "no scent" on Yankee Candles increased.

  • Updated

Select locations are now offering the Pfizer-Biotech vaccine for children ages 5-11, following approval from the Centers for Disease Control and Prevention (CDC) and the Pennsylvania Department of Health (PA DOH). Similar to older age groups, the vaccine requires two doses three weeks apart …

  • Updated

Following FDA approval and CDC authorization of booster doses of Moderna and Johnson & Johnson vaccines, certain locations are now offering all three booster vaccines, including Pfizer. 

COVID-19 continues to be a part of our lives. To say this has been a complex pandemic would be an understatement. However, as time goes on, we continue to see evolution in approaches to providing care that are safe, effective, and saving lives, and on top of that, we have multiple options fo…

  • Updated

The ongoing scientific developments of COVID-19 vaccines continue to produce questions amongst researchers, physicians, and the public. Hospitals look to the FDA and CDC to administer new health practices, including the most recent focus of conversation — booster doses.